NCT05707858

Brief Summary

Food Allergy (FA) is one of the most expensive allergic disorders in the pediatric age, and affecting up to 10% of children worldwide, it is recognized as a global health problem. The Oral Food Challenge (OFC) is the gold standard for FA diagnosis, but it is time-consuming, expensive, and potentially dangerous, as it can determine severe anaphylaxis. In addition, causing long-lasting impact on patient anxiety and mental health due to the physical duress and health risks involved with its application, OFC strategy is little applied in clinical practice with consequent diagnostic errors and delays. The goal of the Naples Pediatric Food Allergy (NAPFA) score is to develop a new clinical score including the main anamnestic, and clinical features for the easy identification of pediatric FA in primary care setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

January 23, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2023

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

5 months

First QC Date

January 23, 2023

Last Update Submit

May 10, 2025

Conditions

Keywords

Food allergy

Outcome Measures

Primary Outcomes (1)

  • Development of a new clinical score for the identification of pediatric FA in primary care setting

    The score will include the main anamnestic and clinical features

    at the enrollment

Secondary Outcomes (2)

  • Development of a new clinical score for the identification of pediatric FA in secondary and tertiary care setting

    at the enrollment

  • Validation of the new clinical NAPFA score for the identification of pediatric FA

    at the enrollment

Study Arms (1)

Subject with suspected food allergy

Other: Development of the NAPFA score

Interventions

In subjects with suspected food allergy we will evaluate main anamnestic, and clinical features to develop the NAPFA score

Subject with suspected food allergy

Eligibility Criteria

Age1 Week - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Subjects consecutively observed at the Pediatric Allergy Program, at the Department of Translational Medical Science of the University of Naples Federico II, both sex, aged 0-14 years with suggestive history of food allergy

You may qualify if:

  • subjects aged between 0-14 years with suggestive history of food allergy

You may not qualify if:

  • chronic systemic diseases,
  • malignancy,
  • immunodeficiency,
  • infectious diseases,
  • autoimmune diseases,
  • inflammatory bowel diseases,
  • celiac disease,
  • metabolic and genetic diseases,
  • cystic fibrosis,
  • chronic pulmonary diseases,
  • gastrointestinal, respiratory, urinary tract and/or cardiovascular malformations,
  • neurologic and/or neuropsychiatric disorders,
  • gastrointestinal tract eosinophilic disorders,
  • use of immunomodulating drugs in the previous 4 months
  • use of steroids and antihistamines in the previous 2 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Traslational Medical Science - University of Naples Federico II

Naples, 80131, Italy

Location

MeSH Terms

Conditions

Food Hypersensitivity

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Roberto Berni Canani, MD

    Department of Translational Medical Science, University of Naples Federico II

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

January 23, 2023

First Posted

February 1, 2023

Study Start

January 23, 2023

Primary Completion

June 22, 2023

Study Completion

December 20, 2023

Last Updated

May 14, 2025

Record last verified: 2025-05

Locations